Immunosuppression-associated eosinophilic pustular folliculitis (Q98956): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 15:36, 16 August 2026
Eosinophilic pustular folliculitis (EPF) arising in the setting of HIV/AIDS or other cause of immunosuppression. In contrast to classical adult EPF it tends to be highly pruritic and is more likely to affect other areas than the face. It may paradoxically appear or worsen after initiation of highly active antiretroviral therapy (HAART) and accompany the immune reconstitution inflammatory syndrome (IRIS).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_2096109620 |
||
| English | Immunosuppression-associated eosinophilic pustular folliculitis |
Eosinophilic pustular folliculitis (EPF) arising in the setting of HIV/AIDS or other cause of immunosuppression. In contrast to classical adult EPF it tends to be highly pruritic and is more likely to affect other areas than the face. It may paradoxically appear or worsen after initiation of highly active antiretroviral therapy (HAART) and accompany the immune reconstitution inflammatory syndrome (IRIS). |
Statements
CID11:ID_2096109620
0 references
dki-india-ID_2096109620
0 references
Concluído
0 references
15 August 2026
0 references
